Hangzhou Jiuyuan Gene Engineering Co., Ltd. is poised to conduct an initial public offering (IPO) of 45,398,800 shares on the Hong Kong Stock Exchange (HKEX) on November 26, following the receipt of approval from the exchange earlier this week. The company has priced each share at 12.56, aiming to raise a maximum of HKD 570 million (USD 73.2 million) through the offering.
IPO Details and Financial Outlook
The IPO represents a significant step for Jiuyuan Gene Engineering as it looks to expand its presence in the biotechnology sector. With the offering, the company is set to capitalize on the growing demand for gene engineering solutions and services. The funds raised through this IPO will be instrumental in supporting the company’s growth strategies and R&D initiatives.-Fineline Info & Tech
Leave a Reply